Simon Piggott

473 total citations
9 papers, 375 citations indexed

About

Simon Piggott is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Physiology. According to data from OpenAlex, Simon Piggott has authored 9 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Critical Care and Intensive Care Medicine and 3 papers in Physiology. Recurrent topics in Simon Piggott's work include Inhalation and Respiratory Drug Delivery (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Cystic Fibrosis Research Advances (3 papers). Simon Piggott is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Cystic Fibrosis Research Advances (3 papers). Simon Piggott collaborates with scholars based in United Kingdom, United States and Switzerland. Simon Piggott's co-authors include Mark Higgins, Benjamin Krämer, Roger Owen, Damon Jack, Michael J. Rosen, Thomas M. Siler, Gregory Feldman, Gerhild Angyalosi, R. S. Vaughan and David Ramos‐Barbón and has published in prestigious journals such as CHEST Journal, British Journal of Anaesthesia and Respiratory Research.

In The Last Decade

Simon Piggott

9 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Piggott United Kingdom 7 251 168 76 53 52 9 375
Francisco Martí Spain 10 87 0.3× 66 0.4× 39 0.5× 32 0.6× 83 1.6× 12 288
J.D. Law-Koune France 6 248 1.0× 44 0.3× 54 0.7× 61 1.2× 41 0.8× 14 364
Tomáš Gabrhelík Czechia 9 53 0.2× 46 0.3× 42 0.6× 113 2.1× 34 0.7× 25 283
Mehtap Honca Türkiye 9 38 0.2× 59 0.4× 25 0.3× 148 2.8× 116 2.2× 32 305
Emily Sussman United States 10 77 0.3× 26 0.2× 38 0.5× 90 1.7× 27 0.5× 10 282
Marc Charbonneau Canada 4 262 1.0× 184 1.1× 33 0.4× 77 1.5× 38 0.7× 4 431
Martin Kryspin Sørensen Denmark 9 67 0.3× 32 0.2× 50 0.7× 76 1.4× 76 1.5× 16 258
Ronald M. Meyer United States 6 131 0.5× 28 0.2× 58 0.8× 68 1.3× 24 0.5× 14 262
Donald M. Mathews United States 10 78 0.3× 15 0.1× 115 1.5× 157 3.0× 64 1.2× 39 318
Öznur Şen Türkiye 9 93 0.4× 13 0.1× 33 0.4× 61 1.2× 27 0.5× 22 184

Countries citing papers authored by Simon Piggott

Since Specialization
Citations

This map shows the geographic impact of Simon Piggott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Piggott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Piggott more than expected).

Fields of papers citing papers by Simon Piggott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Piggott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Piggott. The network helps show where Simon Piggott may publish in the future.

Co-authorship network of co-authors of Simon Piggott

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Piggott. A scholar is included among the top collaborators of Simon Piggott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Piggott. Simon Piggott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Geller, David E., Samya Z. Nasr, Simon Piggott, et al.. (2013). Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group. Respiratory Care. 59(3). 388–398. 33 indexed citations
2.
Konstan, Michael W., Mark Higgins, Gerhild Angyalosi, et al.. (2013). Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial. Current Medical Research and Opinion. 29(8). 947–956. 38 indexed citations
3.
Konstan, Michael W., Mark Higgins, Simon Piggott, et al.. (2012). WS5.6 A challenging double-blind, placebo-controlled study of tobramycin inhalation powder in cystic fibrosis: results of the EDIT trial. Journal of Cystic Fibrosis. 11. S12–S12. 6 indexed citations
4.
Feldman, Gregory, Thomas M. Siler, Damon Jack, et al.. (2010). Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulmonary Medicine. 10(1). 11–11. 101 indexed citations
5.
Vogelmeier, Claus, David Ramos‐Barbón, Damon Jack, et al.. (2010). Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respiratory Research. 11(1). 135–135. 66 indexed citations
6.
Vogelmeier, Claus, David Ramos‐Barbón, Damon Jack, et al.. (2009). ONCE-DAILY INDACATEROL PROVIDES EFFECTIVE 24-HOUR BRONCHODILATION IN COPD: A DOUBLE-BLIND COMPARISON WITH TIOTROPIUM. CHEST Journal. 136(4). 4S–4S. 5 indexed citations
7.
Sanders, Lalage, et al.. (1991). REVERSAL OF BENZODIAZEPINE SEDATION WITH THE ANTAGONIST FLUMAZENIL. British Journal of Anaesthesia. 66(4). 445–453. 24 indexed citations
8.
Jones, Michael, Simon Piggott, R. S. Vaughan, et al.. (1990). Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement.. BMJ. 300(6741). 1683–1687. 69 indexed citations
9.
Piggott, Simon, D. G. Bogod, Michael J. Rosen, Gail Rees, & M. Harmer. (1990). ISOFLURANE WITH EITHER 100% OXYGEN OR 50% NITROUS OXIDE IN OXYGEN FOR CAESAREAN SECTION. British Journal of Anaesthesia. 65(3). 325–329. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Martí Breakdown of academic impact, for papers by J.D. Law-Koune Breakdown of academic impact, for papers by Tomáš Gabrhelík Breakdown of academic impact, for papers by Mehtap Honca Breakdown of academic impact, for papers by Emily Sussman Breakdown of academic impact, for papers by Marc Charbonneau Breakdown of academic impact, for papers by Martin Kryspin Sørensen Breakdown of academic impact, for papers by Ronald M. Meyer Breakdown of academic impact, for papers by Donald M. Mathews Breakdown of academic impact, for papers by Öznur Şen
Rankless by CCL
2026